Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE Examination

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 6, 2021

Primary Completion Date

September 29, 2021

Study Completion Date

September 29, 2021

Conditions
Liver Fibrosis
Interventions
DEVICE

Research FibroScan

"After having obtained the patient's Informed Consent Form signature, the following 3 examinations will be done:~1. Standard examination \[Reference CE-marked FibroScan\]: the operator will need to find an optimal measurement area, and perform 10 valid measurements.~2. Standard examination \[Research FibroScan\]: the operator must take 15 valid measurements at the same measurement point as the one used for the examination with the Reference FibroScan.~3. Exploratory examination \[Research FibroScan\]: the operator needs to perform15 invalid measurements to acquire data in non-optimal regions of measurement (lungs, vessels, intestines, ribs, edges of the liver)."

Trial Locations (6)

Unknown

CHU d'Amiens, Amiens

CHU d'Angers, Angers

CHU de Lille, Lille

Hôpital Saint Eloi, Montpellier

CHU de Nancy, Nancy

CHU de Nice, Nice

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Echosens

INDUSTRY

NCT04747457 - Development of Predictive Indicators of Homogeneous Propagation of Ultrasound and Elastic Waves During VCTE Examination | Biotech Hunter | Biotech Hunter